Trial intelligence / Profile preview

Telmisartan vs Valsartan in Mild to Moderate Hypertension

NCT00034840Phase 4Completed

Sponsor
Boehringer Ingelheim
Start
Oct 2001
Primary completion
Aug 2002
Modality
Small Molecules
Countries
2
01

Overview

A Phase 4 trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Started Oct 2001; status: completed.

02

Drugs

telmisartan
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00034840.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00034840.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call